Skip to content

Efficacy and safety of acupuncture in the treatment of moderate-to-severe persistent allergic rhinitis: a randomized controlled clinical trial

Efficacy and safety of acupuncture in the treatment of moderate-to-severe persistent allergic rhinitis: a randomized controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095634
Enrollment
Unknown
Registered
2025-01-09
Start date
2025-01-20
Completion date
Unknown
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

allergic rhinitis

Interventions

Sponsors

Ningxia Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria of moderate and severe persistent allergic rhinitis (2) the age is between 18 and 65 years old (3) Symptom attack >=4d/ week, and >= 4 consecutive weeks; Currently in the onset of symptoms (4)TNSS score >=4 points (5) Being able to correctly describe my wishes, voluntarily filling in the informed consent form and agreeing to participate in the clinical subjects.

Exclusion criteria

Exclusion criteria: (1) Those who have suffered from respiratory tract infection or acute sinusitis within 14 days; Inflammation on chest X-ray; (2) Those who have a history of chronic paranasal sinusitis or are found to have chronic paranasal sinusitis by X-ray examination of paranasal sinuses; (3) organic lesions in the nasal cavity or nasal surgery; (4) Patients with other paroxysmal respiratory diseases such as asthma; Or complicated with severe liver and kidney dysfunction, cardiovascular and cerebrovascular diseases, mental system diseases and other serious diseases that cannot be treated; (5) Those who have taken H1- antihistamines, steroids and antihistamines, decongestants (acting on nose, mouth and eyes), corticosteroids and antibiotics within 14 days; (6) Patients who have received specific immunotherapy or long-term continuous hormone therapy in the last year; (7) Those who have received physical therapy within the scope of traditional Chinese medicine within 14 days, such as acupuncture, catgut embedding, moxibustion, cupping and nasal inhalation of traditional Chinese medicine; (8) pregnant, lactating or pregnant women; (9) Participants in other clinical trials at the same time; (10) Clinical researchers believe that the subjects participating in clinical research cannot cooperate with the therapists.

Design outcomes

Primary

MeasureTime frame
The Rhinitis Control Assessment Test;

Secondary

MeasureTime frame
RQLQ scale score;TNSS scale score;RMS scale score;TOSS scale score;

Countries

China

Contacts

Public ContactGuo Bin

Ningxia Medical University

guo12200055@163.com+86 186 3549 0771

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026